ClinicalTrials.Veeva

Find clinical trials for COVID-19 in Paris, Île-de-France

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Infections
Communicable Diseases
Coronavirus Infections
Pneumonia
Post-Acute COVID-19 Syndrome
Syndrome
Human Influenza

COVID-19 trials near Paris, Île-de-France, FRA:

Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia (TRICOVID)

pneumonia (CAP) or moderate / severe Coronavirus Disease 2019 (COVID-19) pneumonia.Other objectives are to determine pharmacokineti...

Enrolling
COVID-19
Bacterial Pneumonia
Drug: Placebo (human albumin 1%)
Drug: Trimodulin

Phase 3

Biotest

Paris, France and 58 other locations

Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

known SARS-CoV-2 variants of concern for pre-exposure prophylaxis of COVID-19.The aim of the Phase I/III study (Parent Study) will -...

Active, not recruiting
COVID-19, SARS-CoV-2
Biological: AZD3152 (Parent study Main Cohort)
Biological: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152

Phase 2, Phase 3

AstraZeneca
AstraZeneca

Paris cedex 10, France and 214 other locations

Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study

seek to enroll immunocompromised patients with Lower Tract parainfluenza infection.It also contains a sub-study to enroll patients with severe COVID...

Enrolling
COVID-19
Parainfluenza
Drug: DAS181 COVID-19
Drug: DAS181

Phase 3

Ansun Biopharma

Créteil, Ile-de-France, France and 59 other locations

Study of the Evolution of Olfactory Disorders in Patients With Persistent Loss of Smell Following COVID-19 (ETOC)

The COVID-19 pandemic is a novel medical challenge, particularly because of the systemic nature of this disease. Indeed, COVID...

Enrolling
SARS-CoV-2 Acute Respiratory Disease
Other: Nasal endoscopy
Other: Blood collection
Pasteur Institute
Pasteur Institute

Paris, France

Investigation of the Persistence of SARS-CoV-2 in the Olfactory Mucosa of Patients With Prolonged Symptoms of COVID-19 (NEUROCOVID)

NEUROCOVID is a prospective multicenter study comparing the proportion of patients with SARS-CoV-2 viral RNA at the level of the olfactory clefts in...

Enrolling
Cognitive Disorder
SARS-CoV-2 Infection
Biological: Nasopharyngeal swab for RT-PCR SARS-CoV-2
Fondation Ophtalmologique Adolphe de Rothschild

Paris, France and 1 other location

Understanding the Determinants of Mucosal Immunity and Optimizing the Diagnosis of Infection With SARS-CoV-2 Variants (COVARIANT)

One of the current health challenges in the face of the COVID-19 pandemic that started in Wuhan in 2019, and still responsible for ...

Enrolling
COVID-19
Other: Exhaled Breath Condensate (EBC)
Other: Saliva sample collection
Pasteur Institute
Pasteur Institute

Paris, France

Nintedanib for the Treatment of SARS-Cov-2 Induced Pulmonary Fibrosis (NINTECOR)

Currently, there is no approved treatment for COVID-19 in France, either for the acute phase, nor for the late chronic phase. the i...

Enrolling
SARS-Cov-2 Induced Pulmonary Fibrosis
Drug: Nintedanib 150 MG [Ofev]
Other: Placebo

Phase 3

Assistance Publique - Hôpitaux de Paris

Paris, France

Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients

The purpose of the Phase 2 CSEG101B2201 study is to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants...

Enrolling
Sickle Cell Disease (SCD)
Drug: Crizanlizumab

Phase 2

Novartis
Novartis

Paris 15, France and 56 other locations

Creation of a Prospective Cohort of Healthy and Sick Subjects and of a Collection of Associated Biological Resources, for the Study of the Immune System and of Its Genetic and Environmental Determinants. (CoSImmGEn)

CoSImmGEn is a protocol set up to respond to the current lack of healthy and sick population cohorts. Biological resources from these cohorts allow r...

Enrolling
Immune System and Related Disorders
Genetic: Genetic determinants analysis
Procedure: Sample obtained after surgery performed in the context of care
Pasteur Institute
Pasteur Institute

Paris, France and 3 other locations

Status recently updated

Impact on the Use of Antibiotics of a Multimodal Algorithm for the Diagnosis and Management of Acute Community-acquired Pneumonia in the Emergency Room (PROMCAP)

Reducing antibiotics prescription is still to date, the main goal in low respiratory tract infections (LRTI).Several studies have shown conflicting r...

Enrolling
Active, not recruiting
Community-acquired Pneumonia
Diagnostic Test: multiplex PCR
Diagnostic Test: CRP dosage
Assistance Publique - Hôpitaux de Paris

Paris, France and 1 other location

Clinical trials

Find clinical trialsTrials by location

Research sites

Find research sitesLearn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy NoticeTerms
© Copyright 2024 Veeva Systems